Andrew A. Hindman - Insider Trading & Ownership

Entity
Individual
Location
C/O Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley, NY
Summary
The estimated net worth of Andrew A. Hindman is at least $3.96M dollars as of November 22, 2022. Andrew A. Hindman is the SVP, CHIEF FINANCIAL OFFICER of Theravance Biopharma, Inc. and owns shares of Theravance Biopharma, Inc. (TBPH) stock worth about $3.96M.
All Insider Reports
All Insider Reports

Ownership of Andrew A. Hindman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TBPH Theravance Biopharma, Inc. Svp, Chief Financial Officer $3.96M Nov 18, 2022

Insider Transactions Reported by Andrew A. Hindman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.